Transcat, Inc. (NASDAQ:TRNS) is set to issue its quarterly earnings data after the market closes on Monday, October 23rd.

Transcat (NASDAQ:TRNS) last announced its earnings results on Tuesday, July 25th. The scientific and technical instruments company reported $0.12 earnings per share for the quarter. Transcat had a return on equity of 10.37% and a net margin of 3.03%. The business had revenue of $36.28 million during the quarter. On average, analysts expect Transcat to post $0.6400 EPS for the current fiscal year and $0.7300 EPS for the next fiscal year.

Transcat, Inc. (NASDAQ:TRNS) opened at 13.4268 on Friday. The company’s 50-day moving average price is $13.69 and its 200 day moving average price is $12.69. Transcat, Inc. has a 52 week low of $10.15 and a 52 week high of $15.15. The company has a market cap of $95.72 million, a PE ratio of 21.3124 and a beta of 0.42.

COPYRIGHT VIOLATION WARNING: “Transcat, Inc. (TRNS) Set to Announce Quarterly Earnings on Monday” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at

Separately, Dougherty & Co started coverage on Transcat in a research note on Wednesday, August 23rd. They issued a “buy” rating and a $20.00 target price for the company.

In other news, Director Paul D. Moore sold 4,000 shares of Transcat stock in a transaction on Friday, August 4th. The stock was sold at an average price of $13.00, for a total value of $52,000.00. Following the completion of the sale, the director now directly owns 57,698 shares of the company’s stock, valued at approximately $750,074. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Carl E. Sassano sold 7,500 shares of Transcat stock in a transaction on Monday, July 31st. The shares were sold at an average price of $13.02, for a total value of $97,650.00. Following the completion of the sale, the director now directly owns 79,075 shares of the company’s stock, valued at $1,029,556.50. The disclosure for this sale can be found here. 8.80% of the stock is currently owned by company insiders.

A hedge fund recently raised its stake in Transcat stock. Vanguard Group Inc. grew its position in Transcat, Inc. (NASDAQ:TRNS) by 3.4% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 133,579 shares of the scientific and technical instruments company’s stock after buying an additional 4,450 shares during the period. Vanguard Group Inc. owned 1.88% of Transcat worth $1,623,000 at the end of the most recent reporting period. Institutional investors own 56.24% of the company’s stock.

About Transcat

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Earnings History for Transcat (NASDAQ:TRNS)

Receive News & Stock Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related stocks with our FREE daily email newsletter.